Get started
Author

Naëlle Lombion

Timing of high-dose methotrexate CNS prophylaxis in DLBCL: a multicenter international analysis of 1384 patients
2022 · Matthew R. Wilson, Toby A. Eyre, et al. · Blood · 95
Epidemiological landscape of young patients with multiple myeloma diagnosed before 40 years of age: the French experience
2021 · Alexis Caulier, Murielle Roussel, et al. · Blood · 37
MUB40 Binds to Lactoferrin and Stands as a Specific Neutrophil Marker
2018 · Mark C. Anderson, Thibault Chaze, et al. · Cell chemical biology · 18
PDF
Carfilzomib, venetoclax and dexamethasone for relapsed/refractory multiple myeloma
2020 · Clémentine Boccon‐Gibod, Alexis Talbot, et al. · British Journal of Haematology · 17
PDF
A third anti-SARS-CoV-2 mRNA dose does not overcome the pejorative impact of anti-CD20 therapy and/or low immunoglobulin levels in patients with lymphoma or chronic lymphocytic leukemia
2021 · Milena Kohn, Marc Delord, et al. · Haematologica · 15
PDF
Thiotepa intrathecal injections for myelomatous central nervous system involvement
2021 · Alexis Claudel, Alexis Talbot, et al. · British Journal of Haematology · 11
Development of thrombotic thrombocytopenic purpura during lenalidomide therapy: three new cases and review of literature
2019 · Dikélélé Elessa, Alexis Talbot, et al. · British Journal of Haematology · 11
PDF
Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura
2022 · Mathilde Chanut, Rym Jaidi, et al. · Platelets · 6
Prognostic value of interim FDG PET-CT in patients older than 60 years with diffuse large B-cell lymphoma treated by PMitCEBO plus rituximab. Comparison between Deauville 5-point scale and International Harmonization Project criteria
2022 · Naelle LOMBION, Philippe ROBIN, et al. · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · 6
Early Integration of High Dose Methotrexate to Frontline DLBCL Therapy Does Not Impact CNS Relapse Compared to End of Treatment Delivery: A Multicentre International Analysis of 1384 Patients
2021 · Matthew R Wilson, Toby A. Eyre, et al. · Blood · 2
A Third Anti-Sars-Cov2 mRNA Dose Does Not Overcome the Pejorative Impact of Anti-CD20 Therapy and/or Low Immunoglobulin Level in CLL/Lymphoma Patients
2021 · Maureen Chbat, Milena Kohn, et al. · Blood · 1
PDF
Overview of the French Practice: Therapeutic Strategies in Patient's First Relapse or Refractory Non IgM AL Amyloidosis
2018 · Camille Villesuzanne, Stephanie Harel, et al. · Blood · 1
Optimization of cytapheresis products' storage for CD34+ hematopoietic stem cells viability and function maintenance
2017 · N. Lombion, C. Gouat, et al. · Cytotherapy
Deuxième allogreffe de cellules souches hématopoïétiques en traitement de rattrapage des leucémies aiguës myéloïdes réfractaires ou en rechute après une première allogreffe : une étude de la SFGM-TC
2017 · Naelle Lombion · HAL
Hodgkin lymphoma
2015 · Adrien Grenier, Emmanuelle Tchernonog, et al. · Hématologie
Diffuse large B-cell lymphoma response to Rituximab-PmitCEBO regimen is not predicted by FcγRIIIa158 polymorphism.
2015 · Cristina Bagacean, Naëlle Lombion, et al. · HAL
Valeur diagnostique de la fixation ostéomédullaire diffuse en TEP au 18FDG dans le bilan préthérapeutique du lymphome diffus à grandes cellules B
2013 · N. Keromnes, P.-Y. Le Roux, et al. · Médecine Nucléaire
Works count: 17
Citation count: 220
H-index: 7
I10-index: 7
Year
Topic
Type